These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17575435)

  • 1. [Metabolic diseases and cerebral white matter lesions].
    Yokote K; Sonezaki K; Saito Y
    Nihon Ronen Igakkai Zasshi; 2007 May; 44(3):325-7. PubMed ID: 17575435
    [No Abstract]   [Full Text] [Related]  

  • 2. Skin tags: a useful clinical sign for insulin resistance?
    Crook M
    Eur J Dermatol; 2012; 22(1):5-6. PubMed ID: 22237167
    [No Abstract]   [Full Text] [Related]  

  • 3. The association of metabolic syndrome with executive dysfunction independent of subclinical ischemic brain lesions in Japanese adults.
    Bokura H; Nagai A; Oguro H; Kobayashi S; Yamaguchi S
    Dement Geriatr Cogn Disord; 2010; 30(6):479-85. PubMed ID: 21252541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High blood sugar linked to brain shrinkage. What this means for preventing cognitive decline.
    Harv Health Lett; 2012 Dec; 38(2):3. PubMed ID: 23346624
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperglycemia Reduces Efficiency of Brain Networks in Subjects with Type 2 Diabetes.
    Kim DJ; Yu JH; Shin MS; Shin YW; Kim MS
    PLoS One; 2016; 11(6):e0157268. PubMed ID: 27336309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White matter lesions on magnetic resonance imaging and their relationship with vascular risk factors in memory clinic attenders.
    Lazarus R; Prettyman R; Cherryman G
    Int J Geriatr Psychiatry; 2005 Mar; 20(3):274-9. PubMed ID: 15717341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between diffuse idiopathic skeletal hyperostosis, abdominal aortic calcification and associated metabolic disorders: Data from the Camargo Cohort.
    Pariente-Rodrigo E; Sgaramella GA; Olmos-Martínez JM; Pini-Valdivieso SF; Landeras-Alvaro R; Hernández-Hernández JL
    Med Clin (Barc); 2017 Sep; 149(5):196-202. PubMed ID: 28283270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of dislipemia in patients with metabolic syndrome or diabetes mellitus].
    Millán J;
    Med Clin (Barc); 2007 May; 128(20):786-94. PubMed ID: 17568508
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypertension in the elderly is associated with white matter lesions and cognitive decline.
    van Swieten JC; Geyskes GG; Derix MM; Peeck BM; Ramos LM; van Latum JC; van Gijn J
    Ann Neurol; 1991 Dec; 30(6):825-30. PubMed ID: 1789694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular risk factors and cognitive decline among elderly male twins.
    Gotkine M
    Neurology; 2007 May; 68(21):1871; author reply 1871. PubMed ID: 17515556
    [No Abstract]   [Full Text] [Related]  

  • 11. Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up.
    van Elderen SG; de Roos A; de Craen AJ; Westendorp RG; Blauw GJ; Jukema JW; Bollen EL; Middelkoop HA; van Buchem MA; van der Grond J
    Neurology; 2010 Sep; 75(11):997-1002. PubMed ID: 20837967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Summary of 2009 Annual Continue Education Course: the Cases Presentation And Scientific Symposium on Relationship Between Periodontitis and General Health].
    Society of Periodontology, Chinese Stomatological Association
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 May; 45(5):290-1. PubMed ID: 20654245
    [No Abstract]   [Full Text] [Related]  

  • 13. Hidradenitis suppurativa and the metabolic syndrome.
    Ergun T
    Clin Dermatol; 2018; 36(1):41-47. PubMed ID: 29241751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White matter microstructure and cognitive decline in metabolic syndrome: a review of diffusion tensor imaging.
    Alfaro FJ; Gavrieli A; Saade-Lemus P; Lioutas VA; Upadhyay J; Novak V
    Metabolism; 2018 Jan; 78():52-68. PubMed ID: 28920863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus.
    Jongen C; van der Grond J; Kappelle LJ; Biessels GJ; Viergever MA; Pluim JP;
    Diabetologia; 2007 Jul; 50(7):1509-16. PubMed ID: 17492428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study.
    Verdelho A; Madureira S; Ferro JM; Basile AM; Chabriat H; Erkinjuntti T; Fazekas F; Hennerici M; O'Brien J; Pantoni L; Salvadori E; Scheltens P; Visser MC; Wahlund LO; Waldemar G; Wallin A; Inzitari D;
    J Neurol Neurosurg Psychiatry; 2007 Dec; 78(12):1325-30. PubMed ID: 17470472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral structural and functional changes in type 1 diabetes.
    Stiles MC; Seaquist ER
    Minerva Med; 2010 Apr; 101(2):105-14. PubMed ID: 20467409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of and therapy for cerebral infarction in the aged].
    Uchiyama S
    Nihon Naika Gakkai Zasshi; 2006 Mar; 95(3):420-5. PubMed ID: 16640069
    [No Abstract]   [Full Text] [Related]  

  • 19. Different associations of periventricular and deep white matter lesions with cognition, neuropsychiatric symptoms, and daily activities in dementia.
    Kee Hyung Park ; Lee JY; Na DL; Kim SY; Cheong HK; Moon SY; Shim YS; Park KW; Ku BD; Choi SH; Joo H; Lee JS; Go SM; Kim SH; Kim S; Cha KR; Lee J; Seo SW
    J Geriatr Psychiatry Neurol; 2011 Jun; 24(2):84-90. PubMed ID: 21546648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White matter hyperintensities: a target for the prevention of cognitive decline?
    Leys D; Bombois S
    J Neurol Neurosurg Psychiatry; 2005 Sep; 76(9):1185-6. PubMed ID: 16107344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.